Aripiprazole lauroxil
| CAS No. | 1259305-29-7 | Cat. No. | BCP14993 |
| Name | Aripiprazole lauroxil | ||
| Synonyms | RDC-3317;RDC 3317;RDC3317; ALKS 9070; ALKS 9072; | ||
| Formula | C36H51Cl2N3O4 | M. Wt | 660.71 |
| Description | Aripiprazole lauroxil is a long-acting injectable atypical antipsychotic. It is an N-acyloxymethyl prodrug of aripiprazole that is administered via intramuscular injection once every four to six weeks for the treatment of schizophrenia. Aripiprazole lauroxil was approved by the U.S. FDA on 5 October 2015. | ||
| Pathways | Neuro Signaling Pathway GPCR/G Protein | ||
| Targets | 5 HT Receptor/Serotonin Receptor | ||
Structure
Part data of this page collected from the open network resources, so Biochempartner can not guarantee its accuracy.
For product details of different batches, please contact our Customer
- Service & Tech Support:orders@biochempartner.com
- Website:www.biochempartner.com
Products are for research use only and not for human use. We do not sell to patients.